CAP7.1 for the Treatment of Advanced Stage, Therapy Refractory Lung and Biliary Tract Tumors

NCT02094560 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
45
Enrollment
INDUSTRY
Sponsor class

Stopped The study was terminated to be redesigned for a trial according to EMA proposal.

Conditions

Interventions

Sponsor

CellAct Pharma GmbH

Collaborators